Issue of Additional Tier 1 Capital Notes

RNS Number : 0791S
CYBG PLC
06 March 2019
 

NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO ANY JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO

CYBG PLC

 

LEI: 213800ZK9VGCYYR6O495

 

6 March 2019

 

CYBG PLC announces pricing of issue of £250,000,000 Additional Tier 1 Capital Notes

CYBG PLC ("CYBG") has completed the pricing of its £250,000,000 9.25 per cent. Fixed Rate Reset Perpetual Subordinated Contingent Convertible Notes (the "Notes").

The offering is scheduled to close on 13 March 2019 subject to the satisfaction of the standard processes prior to settlement.  The Notes are convertible into ordinary shares of CYBG in the event the Common Equity Tier 1 Capital Ratio of the CYBG group falls below 7.00 per cent. as described in the conditions of the Notes. For further details, see the Listing Particulars prepared in connection with the Notes which will be available at https://www.cybg.com/investor-centre/debt-investors/.

Application has been made to the Irish Stock Exchange plc, trading as Euronext Dublin ("Euronext Dublin") for the Notes to be admitted to the official list of Euronext Dublin and to trading on the Global Exchange Market of Euronext Dublin.

Enquiries

Investors and Analysts

 

Andrew Downey

07823 443 150

Head of Investor Relations

andrew.downey@cybg.com

 

 

Company Secretary

 

Lorna McMillan

07834 585 436

Company Secretary

lorna.mcmillan@cybg.com

 

 

Media Relations

 

Press Office

0800 066 5998

 

press.office@cybg.com

 

Disclaimer - Intended Addressees

The securities referred to in this announcement are not intended to be sold and should not be sold to retail clients in the European Economic Area, as set out in the Product Intervention (Contingent Convertible Securities and Mutual Society Shares) Instrument 2015 (the "PI Instrument") or the rules set out in the PI instrument (as amended or replaced from time to time), Regulation (EU) No. 1286/2014 on key information documents for packaged and retail and insurance-based investment products ("PRIIPs") and the Markets in Financial Instruments Directive 2014/65/EU (as amended) ("MiFID II" and together with the PI Instrument and PRIIPs, the "Regulations"), other than in accordance with the limited exemptions set out in the Regulations.

Notice to U.S. persons: the Notes have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or the securities laws of any state or other jurisdiction of the United States.

Notice to U.K. persons: this communication has not been approved by an authorised person for the purposes of section 21 of the Financial Services and Markets Act 2000 (as amended) ("FSMA"). Accordingly, this communication is only for distribution to and directed at: (i) in the United Kingdom, persons having professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) (the "Order") and high net worth entities falling within Article 49(2)(a) to (d) of the Order; (ii) persons who are outside the United Kingdom; and (iii) any other person to whom it can otherwise be lawfully distributed (all such persons together being referred to as "Relevant Persons"). Any investment or investment activity to which this communication relates is available only to and will be engaged in only with Relevant Persons. Persons who are not Relevant Persons should not take any action based upon this communication and should not rely on it.

Nothing in this electronic publication constitutes an offer of securities for sale in any jurisdiction where it is unlawful to do so.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IODUGUWAWUPBGAQ
UK 100